WFH/wfh.org
Nov 14, 2026, 14:14
Expanding Global Access to Gene Therapy – WFH
World Federation of Hemophilia shared a post on LinkedIn:
“We wrapped up our 19th New Technology and Gene Therapy (NTGT) Workshop in Montréal today with a question.
How can advances in treatment reach more people with bleeding disorders worldwide?
On Day 2, we explored ways to make gene therapy more durable, emerging treatments for other rare bleeding disorders, and what it takes to expand access.
Thank you to everyone who joined us to mark 30 years of scientific innovation and exchange.
See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 14:11Cedric Hermans: Advancing Haemophilia Care Through Innovation and Global Access
-
Nov 14, 2026, 14:08Bruno Pougault: Lupus Anticoagulant Testing During DOAC Therapy
-
Nov 14, 2026, 14:08Francinny Alves Kelly: AHA Scientific Sessions 2026 Features Research on CHA₂DS₂-VASc and Transhepatic AF Ablation
-
Nov 14, 2026, 14:03Newborn Vitamin K Prophylaxis and the Risk of Bleeding – JAMA
-
Nov 14, 2026, 14:03Denis Oduor: Shaping the Future of Transfusion Medicine at Terumo BCT Africa Hackathon 2026
-
Nov 14, 2026, 14:01Maria Elisa Mancuso: Shaping the Future of Hemophilia Care Together!
-
Nov 14, 2026, 13:58Deniz Aslan: Advancing Pediatric Beta-Thalassemia Screening
-
Nov 14, 2026, 13:56ASPERA-R Study Investigates Anticoagulation Timing Following Breakthrough Ischemic Stroke – International Journal of Stroke
-
Nov 14, 2026, 13:47Karen A. Moffat: New 2026 Issue on Laboratory Diagnostics in Thrombosis and Haemostasis